Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Bellevue Life Sciences A... (BLACU)

Bellevue Life Sciences Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BLACU
DateTimeSourceHeadlineSymbolCompany
21/02/202421:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
13/02/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
08/02/202421:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
05/02/202418:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
16/11/202322:00PR Newswire (US)OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
16/11/202321:37Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
16/11/202321:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
15/11/202311:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
07/11/202321:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
20/10/202321:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
10/10/202322:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
14/08/202321:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/07/202321:58Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/07/202321:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/07/202321:45PR Newswire (US)Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business CombinationNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
28/06/202321:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
14/06/202322:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
22/05/202321:35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
16/05/202313:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
31/03/202321:20Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
27/03/202321:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
27/03/202321:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
27/03/202321:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
14/03/202320:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
14/03/202320:05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Separate Trading of its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
28/02/202322:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
23/02/202321:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
21/02/202321:05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Closing of Full Over-allotment OptionNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
14/02/202321:05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Closing of $60 Million Initial Public OfferingNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BLACU